DAILY BRIEF · 2026-07-21

2026-07-21

FDA Approves First New Active Sunscreen Ingredient in Decades Verified with 1 independent source domain, 3 evidence object(s), 1 grounded fact(s), and confidence 0.70.

FDA APPROVAL

FDA Approves First New Active Sunscreen Ingredient in Decades

cand_6f324c1c-d15f-5700-b64f-68c346e5ec8d: 1 verified canonical event across 1 event type, supported by 1 independent source domain.

Confidence 0.70 · 1 source domain(s) · 3 evidence objects

PARTNERSHIP

Phanes Therapeutics Announces Expansion of Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate Spevatamig in Combination with KEYTRUDA® (Pembrolizumab) and Chemotherapy for Treatment of Biliary Tract Cancer

cand_c910827d-042b-5b61-8f68-c1cc163d5073: 1 verified canonical event across 1 event type, supported by 1 independent source domain.

Confidence 0.70 · 1 source domain(s) · 5 evidence objects

PARTNERSHIP

ELEPHAS ANNOUNCES COMMERCIAL PARTNERSHIP WITH INVITROCUE TO EXPAND PERSONALIZED ONCOLOGY IN SOUTHEAST ASIA

cand_1725bb45-380f-58ab-a437-be35b255dc2d: 1 verified canonical event across 1 event type, supported by 1 independent source domain.

Confidence 0.70 · 1 source domain(s) · 4 evidence objects